DarioHealth Corp. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
DarioHealth Corp. (DRIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 4.23% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2026-03-19
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2019-09-30 was 1.42%, a 51.37% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2019-06-30 was 2.28%, a 17.69% decline year-over-year.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2018-09-30 was 2.92%.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2018-06-30 was 2.77%.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2025 was 4.23%, a 10.38% decline from fiscal 2024.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2024 was 4.72%.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2016 was 0.99%, a 35.71% decline from fiscal 2015.
- DarioHealth Corp. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2015 was 1.54%, a 45.77% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|
| 2025-12-31 | 4.23% 10-K · filed 2026-03-19 | |
| 2024-12-31 | 4.72% 10-K · filed 2026-03-19 | |
| 2019-09-30 | 1.42% 10-Q · filed 2019-10-28 | |
| 2019-06-30 | 2.28% 10-Q · filed 2019-08-13 | |
| 2018-09-30 | 2.92% 10-Q · filed 2019-10-28 | |
| 2018-06-30 | 2.77% 10-Q · filed 2019-08-13 | |
| 2016-12-31 | 0.99% 10-K · filed 2017-03-22 | |
| 2015-12-31 | 1.54% 10-K · filed 2017-03-22 | |
| 2014-12-31 | 2.84% 10-K · filed 2016-02-08 | |
| 2013-12-31 | 2.98% 10-K · filed 2015-03-24 | |
| 2012-12-31 | 0.96% 10-K · filed 2014-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |